SKYI (Sky Century Investment) 9-Day RSI: 42.41 (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SKYI Sky Century Investment Inc SKYI
29 GF Score
Price $0.21
! 6 Warning Signs
View Full Analysis

What is Sky Century Investment 9-Day RSI?

Sky Century Investment SKYI -24.70% 29 9-Day RSI is 42.41 as of Jul. 31, 2026. GuruFocus rates SKYI with a GF Score™ of 29/100. The stock has 6 warning signs investors should review. Among 1,047 Drug Manufacturers companies, Sky Century Investment ranks better than 60.27% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-31), Sky Century Investment's 9-Day RSI is 42.41.

The industry rank for Sky Century Investment's 9-Day RSI or its related term are showing as below:

SKYI's 9-Day RSI is ranked better than
60.27% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 46.02 vs SKYI: 42.41

Sky Century Investment  (OTCPK:SKYI) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Sky Century Investment 9-Day RSI Related Terms


SKYI vs SHPH, PLSH, CPMD: 9-Day RSI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sky Century Investment's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sky Century Investment 9-Day RSI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sky Century Investment's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Sky Century Investment's 9-Day RSI falls into.


SKYI
29GF Score
Sky Century Investment Inc SKYI
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sky Century Investment  (OTCPK:SKYI) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 9-Day RSI →
What does a 9-Day RSI of 42.41 mean?
Sky Century Investment (SKYI) has a 9-Day RSI of 42.41 as of Jul. 31, 2026. According to the industry distribution chart, Sky Century Investment ranks #416 out of 1047 companies in the Drug Manufacturers industry, placing it in the top 39.7%.
Is Sky Century Investment's 9-Day RSI too high?
Sky Century Investment's current 9-Day RSI is 42.41. The Drug Manufacturers industry median 9-Day RSI is 46.02. Sky Century Investment's value of 42.41 is 7.8% below this industry median. Based on the distribution chart, Sky Century Investment ranks #416 out of 1047 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sky Century Investment has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Sky Century Investment's 9-Day RSI compare to SHPH and PLSH?
According to the Drug Manufacturers industry distribution chart, Sky Century Investment ranks #416 out of 1047 companies for 9-Day RSI. This puts Sky Century Investment in the upper half of its industry. The industry median 9-Day RSI is 46.02. Sky Century Investment's value of 42.41 is 7.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Drug Manufacturers company?
The median 9-Day RSI among Drug Manufacturers companies is 46.02, based on 1,047 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sky Century Investment's current 9-Day RSI of 42.41 is 7.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median 9-Day RSI is 46.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sky Century Investment's current 9-Day RSI is 42.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sky Century Investment stock overvalued right now?
Sky Century Investment (SKYI) has a current 9-Day RSI of 42.41. The current 9-Day RSI is 42.41 and 7.8% below the Drug Manufacturers industry median of 46.02. Sky Century Investment's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Sky Century Investment (SKYI), the current 9-Day RSI is 42.41 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sky Century Investment Business Description

Address 220 Emerald Vista Way, No. 233, Las Vegas, NV, USA, 89144
Sky Century Investment Inc operates four primary business lines, with profits generated from IT Services, including Technical Support and Server Leasing, and from the sale of RSS feeds and Podcasts. The IT Services segment provides ongoing technical support, maintenance, system upgrades, and high-performance server leasing, supporting growing demand for cloud solutions, data management, and network infrastructure. The Company also owns the Cannabis News application, a mobile platform that aggregates cannabis-related news from diverse sources and delivers real-time updates, though it is not commercially viable and has not generated revenue to date. The Company operates in competitive markets across IT services, marketing services, RSS feed services, and the cannabis industry.
29GF Score

Get the complete analysis for SKYI

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price